Adjuvant immune checkpoint blockade revisited; the need to consider more factors and involve all stakeholders

• Alexander van Akkooi,
• Violeta Astratinei,
• Koen van Elst,
• Lotte Steuten

Affiliations

Alexander van Akkooi

Melanoma Institute Australia, The University of Sydney and Royal Prince Albert Hospital, Sydney, Australia; Corresponding author.

Violeta Astratinei

Stichting Melanoom, Amstelveen, the Netherlands

Koen van Elst

Stichting Melanoom, Amstelveen, the Netherlands

Lotte Steuten

Office of Health Economics, London, UK